Harry Stylli - Net Worth and Insider Trading

Harry Stylli Net Worth

The estimated net worth of Harry Stylli is at least $703,041 dollars as of 2024-04-25. Harry Stylli is the Chairman & CEO, 10% Owner of Biora Therapeutics Inc and owns about 584,675 shares of Biora Therapeutics Inc (BIOR) stock worth over $362,440. Harry Stylli is also the President and CEO of Sequenom Inc and owns about 142,511 shares of Sequenom Inc (SQNM) stock worth over $340,601. Details can be seen in Harry Stylli's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Harry Stylli has not made any transactions after 2020-12-02 and currently still holds the listed stock(s).

Transaction Summary of Harry Stylli

To

Harry Stylli Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Harry Stylli owns 2 companies in total, including Biora Therapeutics Inc (BIOR) , and Sequenom Inc (SQNM) .

Click here to see the complete history of Harry Stylli’s form 4 insider trades.

Insider Ownership Summary of Harry Stylli

Ticker Comapny Transaction Date Type of Owner
BIOR Biora Therapeutics Inc 2020-12-02 director & Chairman & CEO
SQNM Sequenom Inc 2009-03-13 director & President and CEO

Harry Stylli Latest Holdings Summary

Harry Stylli currently owns a total of 2 stocks. Among these stocks, Harry Stylli owns 584,675 shares of Biora Therapeutics Inc (BIOR) as of December 2, 2020, with a value of $362,440 and a weighting of 51.55%. Harry Stylli also owns 142,511 shares of Sequenom Inc (SQNM) as of March 13, 2009, with a value of $340,601 and a weighting of 48.45%.

Latest Holdings of Harry Stylli

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BIOR Biora Therapeutics Inc 2020-12-02 584,675 0.62 362,440
SQNM Sequenom Inc 2009-03-13 142,511 2.39 340,601

Holding Weightings of Harry Stylli


Harry Stylli Form 4 Trading Tracker

According to the SEC Form 4 filings, Harry Stylli has made a total of 3 transactions in Biora Therapeutics Inc (BIOR) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Biora Therapeutics Inc is the acquisition of 6,116 shares on December 2, 2020, which cost Harry Stylli around $499,999.

According to the SEC Form 4 filings, Harry Stylli has made a total of 0 transactions in Sequenom Inc (SQNM) over the past 5 years. The most-recent trade in Sequenom Inc is the acquisition of 2,000 shares on March 13, 2009, which cost Harry Stylli around $26,860.

Insider Trading History of Harry Stylli

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Harry Stylli Trading Performance

GuruFocus tracks the stock performance after each of Harry Stylli's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Harry Stylli is 5.16%. GuruFocus also compares Harry Stylli's trading performance to market benchmark return within the same time period. The performance of stocks bought by Harry Stylli within 3 months outperforms 4 times out of 8 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Harry Stylli's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Harry Stylli

Average Return

-1.05%

Average return per transaction

Outperforming Transactions

25%

2 out of 8 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.37 5.16 4.83 -1.05 13.33 -31.33
Relative Return to S&P 500(%) 6.09 0.45 -7.9 -23.62 3.54 -37.72

Harry Stylli Ownership Network

Ownership Network List of Harry Stylli

No Data

Ownership Network Relation of Harry Stylli


Harry Stylli Owned Company Details

What does Biora Therapeutics Inc do?

Who are the key executives at Biora Therapeutics Inc?

Harry Stylli is the director & Chairman & CEO of Biora Therapeutics Inc. Other key executives at Biora Therapeutics Inc include 10 percent owner Athyrium Opportunities Iii Co-invest 1 Lp , director & Chief Executive Officer Aditya P. Mohanty , and 10 percent owner Athyrium Capital Management, Lp .

Biora Therapeutics Inc (BIOR) Insider Trades Summary

Over the past 18 months, Harry Stylli made no insider transaction in Biora Therapeutics Inc (BIOR). Other recent insider transactions involving Biora Therapeutics Inc (BIOR) include a net purchase of 12,506,250 shares made by Athyrium Opportunities Iii Co-invest 1 Lp ,

In summary, during the past 3 months, insiders sold 0 shares of Biora Therapeutics Inc (BIOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biora Therapeutics Inc (BIOR) were sold and 500,250 shares were bought by its insiders, resulting in a net purchase of 500,250 shares.

Biora Therapeutics Inc (BIOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biora Therapeutics Inc Insider Transactions

No Available Data

Harry Stylli Mailing Address

Above is the net worth, insider trading, and ownership report for Harry Stylli. You might contact Harry Stylli via mailing address: 3595 John Hopkins Ct, San Diego Ca 92121.

Discussions on Harry Stylli

No discussions yet.